Recalcitrant cystoid macular oedema in an eye with ischaemic central retinal vein occlusion- what's next?

Research output: Contribution to journalArticle

Abstract

We report a case of a middle-aged gentleman with recalcitrant macular oedema (RMO) secondary to ischaemic central retinal vein occlusion (CRVO). He was given six injections of intravitreal ranibizumab (anti-VEGF) monthly. However, his visual acuity (VA) deteriorated and the macular oedema worsened. He then received an intravitreal dexamethasone implant eight months post-CRVO. His VA and macular oedema improved dramatically and significantly at first follow-up and remained stable at six months after implant. This case can be a reference for those who treating recalcitrant macular oedema. It shows the effect of an intravitreal dexamathasone implant might have in a patient with RMO due to CRVO. The patient enjoyed improvement of vision, with clinical evidence of reduction in central macular thickness (CMT) and with no serious adverse events after a single injection up to six months post implant.

Original languageEnglish
Pages (from-to)358-360
Number of pages3
JournalMedical Journal of Malaysia
Volume70
Issue number6
Publication statusPublished - 1 Dec 2015

Fingerprint

Retinal Vein
Retinal Vein Occlusion
Macular Edema
Visual Acuity
Intravitreal Injections
Dexamethasone
Vascular Endothelial Growth Factor A
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Recalcitrant cystoid macular oedema in an eye with ischaemic central retinal vein occlusion- what's next? / Yong, Meng Hsien; Ahem, Amin; Mustapha, Mushawiahti; Bastion, Mae-Lynn Catherine.

In: Medical Journal of Malaysia, Vol. 70, No. 6, 01.12.2015, p. 358-360.

Research output: Contribution to journalArticle

@article{16b83e03deca4daea841d30aa9018e85,
title = "Recalcitrant cystoid macular oedema in an eye with ischaemic central retinal vein occlusion- what's next?",
abstract = "We report a case of a middle-aged gentleman with recalcitrant macular oedema (RMO) secondary to ischaemic central retinal vein occlusion (CRVO). He was given six injections of intravitreal ranibizumab (anti-VEGF) monthly. However, his visual acuity (VA) deteriorated and the macular oedema worsened. He then received an intravitreal dexamethasone implant eight months post-CRVO. His VA and macular oedema improved dramatically and significantly at first follow-up and remained stable at six months after implant. This case can be a reference for those who treating recalcitrant macular oedema. It shows the effect of an intravitreal dexamathasone implant might have in a patient with RMO due to CRVO. The patient enjoyed improvement of vision, with clinical evidence of reduction in central macular thickness (CMT) and with no serious adverse events after a single injection up to six months post implant.",
author = "Yong, {Meng Hsien} and Amin Ahem and Mushawiahti Mustapha and Bastion, {Mae-Lynn Catherine}",
year = "2015",
month = "12",
day = "1",
language = "English",
volume = "70",
pages = "358--360",
journal = "Medical Journal of Malaysia",
issn = "0300-5283",
publisher = "Malaysian Medical Association",
number = "6",

}

TY - JOUR

T1 - Recalcitrant cystoid macular oedema in an eye with ischaemic central retinal vein occlusion- what's next?

AU - Yong, Meng Hsien

AU - Ahem, Amin

AU - Mustapha, Mushawiahti

AU - Bastion, Mae-Lynn Catherine

PY - 2015/12/1

Y1 - 2015/12/1

N2 - We report a case of a middle-aged gentleman with recalcitrant macular oedema (RMO) secondary to ischaemic central retinal vein occlusion (CRVO). He was given six injections of intravitreal ranibizumab (anti-VEGF) monthly. However, his visual acuity (VA) deteriorated and the macular oedema worsened. He then received an intravitreal dexamethasone implant eight months post-CRVO. His VA and macular oedema improved dramatically and significantly at first follow-up and remained stable at six months after implant. This case can be a reference for those who treating recalcitrant macular oedema. It shows the effect of an intravitreal dexamathasone implant might have in a patient with RMO due to CRVO. The patient enjoyed improvement of vision, with clinical evidence of reduction in central macular thickness (CMT) and with no serious adverse events after a single injection up to six months post implant.

AB - We report a case of a middle-aged gentleman with recalcitrant macular oedema (RMO) secondary to ischaemic central retinal vein occlusion (CRVO). He was given six injections of intravitreal ranibizumab (anti-VEGF) monthly. However, his visual acuity (VA) deteriorated and the macular oedema worsened. He then received an intravitreal dexamethasone implant eight months post-CRVO. His VA and macular oedema improved dramatically and significantly at first follow-up and remained stable at six months after implant. This case can be a reference for those who treating recalcitrant macular oedema. It shows the effect of an intravitreal dexamathasone implant might have in a patient with RMO due to CRVO. The patient enjoyed improvement of vision, with clinical evidence of reduction in central macular thickness (CMT) and with no serious adverse events after a single injection up to six months post implant.

UR - http://www.scopus.com/inward/record.url?scp=84957048708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957048708&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84957048708

VL - 70

SP - 358

EP - 360

JO - Medical Journal of Malaysia

JF - Medical Journal of Malaysia

SN - 0300-5283

IS - 6

ER -